Comparing two doses of fertility medication for IVF
Part of Women’s health & pregnancy clinical trials.
This trial compares two doses of follicle-stimulating hormone (FSH) to find out which dose helps women with normal ovarian reserve have better IVF outcomes. It aims to improve the chances of a successful pregnancy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a BMI between 18 and 30.
- Your AMH levels are between 1.2 and 3.5 ng/mL, meaning normal egg supply.
- Your antral follicle count is between 8 and 20, also indicating normal egg supply.
- This is your first or second IVF/ICSI treatment cycle.
- You are planning to use a GnRH antagonist protocol, a specific medicine for IVF.
- You do not have severe endometriosis, uncontrolled hormone conditions, or severe male factor infertility.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial compares two different medications (Corifollitropin alpha and daily rFSH) to stimulate egg production in healthy egg donors. It aims to see if a single injection of Corifollitropin alpha works as well as the usual daily shots, making the process simpler and more comfortable.
This trial tests two different starting doses of a fertility drug (follicle-stimulating hormone, or FSH) during a specific IVF preparation method called PPOS. The goal is to see which dose leads to better egg development for women with good fertility prospects.
This study compares two fertility medications (rFSH and hMG) to see how they affect the cells around your eggs and the quality of embryos. It may help you and your doctor choose the best stimulation drug for your IVF cycle.
This study compares two ways of giving fertility medication to stimulate the ovaries before retrieving eggs for IVF (in vitro fertilization). One method starts after ovulation and uses a drug called Elonva without a routine blocking medication, while the other is the standard approach starting early in the cycle. The goal is to see which approach leads to better outcomes for people undergoing IVF or ICSI (a procedure where a single sperm is injected into an egg).
This trial tests two different intensities of ovarian stimulation for women undergoing IVF with genetic testing of embryos. It aims to see which approach leads to more healthy embryos ready for transfer.
This trial tests a fertility drug called follitropin delta for women undergoing IVF. It checks if using this drug with a specific hormone-lowering protocol helps produce eggs for fertilisation.
Hear when a new Infertility, Female trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.